DCN Dx
DCN Dx specializes in the development of lateral flow diagnostics, focusing on the creation and commercialization of rapid diagnostic tests. The company offers contract development services to clients in the medical, veterinary, and consumer diagnostics sectors, assisting them in exploring and developing point-of-care tests. DCN Dx provides comprehensive support, including training and resources for the development of lateral flow assays and related products, aiming to facilitate the successful commercialization of these diagnostic solutions.
2 past transactions
Biomed Diagnostics
Acquisition in 2022
Biomed Diagnostics manufactures and supplies specialized culture media devices designed for transporting, isolating, and differentiating biological samples in clinical, veterinary, and scientific settings. Their product range includes highly selective, pre-plated prepared-media culture devices that aim to reduce laboratory labor and costs by streamlining microbiological testing processes. The company caters to medical professionals, veterinarians, researchers, and environmental scientists globally, enabling accurate detection, identification, enumeration, and differentiation of pathogens and non-pathogens.
IVD Vision
Acquisition in 2021
IVD Vision is to help bring your diagnostic product to market with their off-the-shelf point-of-care reader systems and custom software and instrumentation development services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.